Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo Coronary Artery Disease: the ENCORE-I Study

NCT04591938 is registered in ClinicalTrials.gov with Joost Daemen as lead sponsor.

NCT NCT04591938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo Coronary Artery Disease: the ENCORE-I Study
Lead sponsor
Joost Daemen
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2019
Completion date
December 31, 2025
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial revascularization, percutaneous coronary intervention, tomography, optical coherence